JP Morgan lowered the bet to 14.10% in Dr. Reddy’s Lab | Mar’20 qtr.

dr. reddy's logo

The Indian pharmaceutical company, Dr. Reddy’s Laboratories– manufactures and markets for numerous medications, kits, drugs etc. The company held 73.01% of the shareholding through public, 26.76% through promoters and 0.24% through non-promoters, in both the quarters of Dec’19 and Mar’20. Comparison of both the quarters’ public shareholding patterns, are as follows:

Increase in Shareholding % – Alternate Investment Funds appeared with a rise from 0.09% to 0.11%. Foreign Portfolio Investors reported growth from 30.04% to 30.15%. LIFE INSURANCE CORPORATION OF INDIA incremented from 4.84% to 5.10%. Bodies Corporate extended the parts from 3.85% to 4.40%. ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED upgraded the stakes from 1.15% to 1.28%. Holdings through Clearing Members expanded from 0.14% to 0.41%. Share percentage through Non-Resident Indians (NRI) up-stepped from 1.02% to 1.05%. Trusts expanded the value from 0.82% to 1.05%.

Decrease in shareholding % – Mutual Funds lowered the total percentage from 9.29% to 8.75%. Franklin Templeton Mutual Fund and their associates reduced the stakes from 2.42% to 1.24%. Financial Institutions/ Banks lessened from 0.20% to 0.15%. Insurance Companies shrunk from 5.51% to 5.34%. Individuals with share capital up to Rs. 2 Lacs contracted from 7.21% to 7.03%. JP MORGAN CHASE BANK (Overseas Depositories) went from 14.31% to 14.10%.

Following had Unaltered shareholding % in March 2020 quarter – Central Government/ State Government(s)/ President of India at 0.00%, Individuals with share capital in excess of Rs. 2 Lacs at 0.15%, Unclaimed or Suspense or Escrow Account at 0.23% and IEPF at 0.13%.

Aditya Birla Sun Life Trustee Pvt Limited and their associates at 1.08%(Dec) and FIRST STATE INVESTMENTS ICVC- STEWART INVESTORS ASIA PACIFIC LEADERS FUND at 2.76%(Dec) might have completely exited or dipped below 1.00% in the March’20 quarter.


Please enter your comment!
Please enter your name here